Deep TMS system to treat OCDOctober 10, 2018
BrainsWay Ltd has received clearance from the US FDA for its deep transcranial magnetic stimulation (Deep TMS) system for the treatment of obsessive-compulsive disorder (OCD) in adults.
Deep TMS system is the first non-invasive medical device for the treatment of OCD. The system was granted approval in 2013 for the treatment of treatment-resistant major depressive disorder (MDD).
BrainsWay’s Deep TMS technology differs from that of other focal TMS devices as it can directly stimulate areas of the brain at a greater depth and breadth. The device can target previously unreachable areas of the brain with its H7-coil, allowing it to effectively treat OCD as well. Clinics that have a Deep TMS systems can now treat MDD and OCD patients, the company said.